PAR 0.00% 20.0¢ paradigm biopharmaceuticals limited..

Ann: PARADIGM RECEIVES FEEDBACK FROM US FDA ON IND SUBMISSION, page-89

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 42 Posts.
    lightbulb Created with Sketch. 7
    agreed. typically our SP has fallen quite dramatically after delays, this however appears to be different - can only assume that was the final hurdle before IND. hopefully we dont cock up the revision to screening and arent sitting on hands. i imagine the IND will set up some price discovery for PAR.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.